brand logo

Am Fam Physician. 2024;110(4):433

CLINICAL QUESTION

Is benzyl benzoate 25% or permethrin 5% more effective for the topical treatment of scabies in adolescents and adults?

BOTTOM LINE

Benzyl benzoate 25% was significantly more effective than permethrin 5% (number needed to treat = 2). It was also associated with more skin irritation, but this adverse event was generally mild to moderate and transient. (Level of Evidence = 1b)

SYNOPSIS

Researchers at one institution in Austria recruited 110 patients, 12 years and older, with dermoscopically diagnosed scabies. Patients with crusted scabies and those who had been treated for scabies in the previous 3 weeks were excluded. The patients' mean age was 28 years; 22% had been treated with topical permethrin, and 12% had been treated with oral ivermectin in the previous 3 months (the dosage of the latter was often judged to have been inadequate). The patients were randomized to receive topical benzyl benzoate 25% or permethrin 5% daily for 3 days in a double-blind fashion. The primary outcome of the absence of mites at 3 to 4 weeks after treatment occurred significantly more often in the benzyl benzoate group (87% vs. 27%; P < .001; number needed to treat = 2). However, mild to moderate burning or stinging was reported more often in the benzyl benzoate group (43% vs. 6%; P < .001; number needed to harm = 3). The skin irritation was short-lived and resolved spontaneously. Benzyl benzoate is widely available over the counter and is inexpensive.

Already a member/subscriber?  Log In

Subscribe

From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see https://www.essentialevidenceplus.com/Home/Loe?show=Sort.

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

This series is coordinated by Natasha J. Pyzocha, DO, contributing editor.

A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.

Continue Reading

More in AFP

More in PubMed

Copyright © 2024 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.